Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases

Vallés AS, Barrantes FJ.

Cells. 2023 Aug 11;12(16):2051. doi: 10.3390/cells12162051.

The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice

Mentzelou M, Dakanalis A, Vasios GK, Gialeli M, Papadopoulou SK, Giaginis C.

Nutrients. 2023 May 11;15(10):2270. doi: 10.3390/nu15102270.

The Role of Hydrogen Sulfide in Regulation of Cell Death following Neurotrauma and Related Neurodegenerative and Psychiatric Diseases

Rodkin S, Nwosu C, Sannikov A, Raevskaya M, Tushev A, Vasilieva I, Gasanov M.

Int J Mol Sci. 2023 Jun 28;24(13):10742. doi: 10.3390/ijms241310742.

Natural products for the treatment of neurodegenerative diseases

Cui D, Chen Y, Ye B, Guo W, Wang D, He J.

Phytomedicine. 2023 Dec;121:155101. doi: 10.1016/j.phymed.2023.155101. Epub 2023 Sep 18.

Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications

Kontoghiorghes GJ.

Int J Mol Sci. 2023 Aug 18;24(16):12928. doi: 10.3390/ijms241612928.

Neuro-Urology and Biobanking: An Integrated Approach for Advancing Research and Improving Patient Care

Botter SM, Kessler TM.

Int J Mol Sci. 2023 Sep 19;24(18):14281. doi: 10.3390/ijms241814281.

Urgent needs of caregiving in ageing populations with Alzheimer's disease and other chronic conditions: Support our loved ones

Culberson JW, Kopel J, Sehar U, Reddy PH.

Ageing Res Rev. 2023 Sep;90:102001. doi: 10.1016/j.arr.2023.102001. Epub 2023 Jul 5.

GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders

Nicoletti F, Di Menna L, Iacovelli L, Orlando R, Zuena AR, Conn PJ, Dogra S, Joffe ME.

Neuropharmacology. 2023 Sep 1;235:109569. doi: 10.1016/j.neuropharm.2023.109569. Epub 2023 May 2.

Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview

Raut S, Bhalerao A, Powers M, Gonzalez M, Mancuso S, Cucullo L.

Cells. 2023 Aug 8;12(16):2019. doi: 10.3390/cells12162019.

The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain

Maran JJ, Adesina MM, Green CR, Kwakowsky A, Mugisho OO.

Ageing Res Rev. 2023 Jul;88:101954. doi: 10.1016/j.arr.2023.101954. Epub 2023 May 13.

Effect of arctigenin on neurological diseases: A review

Li M, Jiang H, Wang Y, Xu Z, Xu H, Chen Y, Zhu J, Lin Z, Zhang M.

J Ethnopharmacol. 2023 Oct 28;315:116642. doi: 10.1016/j.jep.2023.116642. Epub 2023 May 24.

Deep brain stimulation of fornix in Alzheimer's disease: From basic research to clinical practice

Liu Z, Shu K, Geng Y, Cai C, Kang H.

Eur J Clin Invest. 2023 Aug;53(8):e13995. doi: 10.1111/eci.13995. Epub 2023 Apr 10.

Applications of Artificial Intelligence to Diagnosis of Neurodegenerative Diseases

Feng T.

Stud Health Technol Inform. 2023 Nov 23;308:648-655. doi: 10.3233/SHTI230896.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias